Value-Based Reimbursement In The Next Normal
In our mapping of the post-pandemic market, one key issue is how health plans will reimburse provider organizations in the year ahead. Anecdotally, we’re seeing more health plan managers looking for provider organizations that can accept value-based reimbursement (VBR) arrangements—particularly arrangements with financial risk. And that makes sense from a macro market perspective. Most analysts predict decreased funding by payers —both government and employers— following the pandemic, and risk-based financial arrangements with provider organizations are one way to align incentives.
A recent market event confirms this …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.